Adenosine A2A Receptor-Antagonist/Dopamine D2 Receptor-Agonist Bivalent Ligands as Pharmacological Tools to Detect A2A-D2 Receptor Heteromers | Journal of Medicinal Chemistry
Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion | Neuropsychopharmacology
Conformational Constraint between Aromatic Residue Side Chains in the “Message” Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist | Journal of
Biomedicines | Free Full-Text | Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Antagonists of the kappa opioid receptor - ScienceDirect
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens | Neuropsychopharmacology
Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit - ScienceDirect
Frontiers | The Signaling and Pharmacology of the Dopamine D1 Receptor
Advances in the Treatment of Chronic Pain by Targeting GPCRs | Biochemistry
Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials | Neuropsychopharmacology
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Kappa opioid receptor activation increases thermogenic energy expenditure which drives increased feeding - ScienceDirect
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
κ-opioid receptor - Wikipedia
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
![Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/cn9000236/asset/images/medium/cn-2009-000236_0007.gif "Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience")